Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor arabinofuranosylcytosines from Yamasa

Feb. 13, 1998

Chiroscience and Bristol-Myers Squibb collaborate on MMP inhibitors for cancer

Feb. 12, 1998

Chinese investigators evaluate new MDR-reversing agent

Feb. 12, 1998

Celltech reports crosslinked antibodies for cancer indications

Feb. 12, 1998

Targeted Genetics to report tgDCC-E1A clinical data

Feb. 11, 1998

Topoisomerase I inhibitor tested in phase I trial

Feb. 11, 1998

Vorozole safe and effective in phase II EORTC study

Feb. 11, 1998

GeneMedicine and Corange progress in cancer alliance

Feb. 11, 1998

Novel mitomycin C derivative reported by Sagami

Feb. 11, 1998

Clinical results of LHRH antagonist in BPH and prostate cancer

Feb. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.